Prevalence of Glucose-6-Phosphate Dehydrogenase Deficiency in Newborns in Northeast Mexico.

Autor:	Villarreal-Martínez L; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Torres-Sánchez KA; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Ibarra-Ramírez M; Genetics Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Martínez-Garza LE; Genetics Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Villarreal-Martínez DZ; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Viera DAG; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Herrera MDCR; Genetics Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., O-Castillo M; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Bautista-Gómez AJ; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., Martínez AG; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México., de la Garza JFM; Hematology Department, Hospital Universitario ̈Dr. José Eleuterio González̈ Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.
Jazyk:	angličtina
Zdroj:	American journal of perinatology [Am J Perinatol] 2024 May; Vol. 41 (S 01), pp. e573-e576. Date of Electronic Publication: 2022 Aug 17.
DOI:	10.1055/a-1926-0075
Abstrakt:	Objective: Glucose-6-phosphate dehydrogenase deficiency (G6PDd) is the most common enzymatic disease worldwide and the prevalence is not well established because of the lack of screening. This study aimed to estimate the prevalence of G6PDd in a Hispanic population from Northeast Mexico. Study Design: In this retrospective study, a database was used to analyze the G6PDd in neonates included in the expanded newborn metabolic screening of inherited metabolic disorders during a period of 4 years through the GSP Neonatal G6 kit (PerkinElmer). Results: Among 96,152 (48,462 male) neonates screened for G6PD enzyme activity, a total of 566 (0.58%) cases were deficient for G6PD. Of those 566 patients, 469 (82.8%) attended the second test and the other 97 (17.2%) patients were lost. Of those 469 who did attend, 384 (81.9%) neonates were deficient in the second test and 85 (18.1%) were normal. With the data collected, 384 neonates were confirmed with G6PDd, 348 (88.6%) were male and 36 (11.4%) patients were female. The calculated prevalence for this population was 0.72 cases per 100 male newborns. Conclusion: The prevalence of G6PDd in the Northeastern Mexican population is high. Since migration is increasing in the United States, pediatricians should be aware of the need to search for G6PDd in newborns and the wide clinical manifestations they can present. Key Points: · The calculated prevalence of glucose-6-phosphate dehydrogenase deficiency in Northeast Mexico is 3.99 cases per 1,000 newborns.. · Glucose-6-phosphate dehydrogenase deficiency screenings should be included in all newborn metabolic screenings.. · Glucose-6-phosphate dehydrogenase deficiency is a common erythroenzymopathy that must be addressed as a public health concern. To anticipate clinical complications, target population monitoring is required.. Competing Interests: None declared. (Thieme. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu